Search results
Results from the WOW.Com Content Network
The McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD) is a 10-question self-report screening tool used to identify individuals who may warrant further evaluation for borderline personality disorder (BPD). The questionnaire asks individuals about the presence of symptoms they experience that are characteristic of BPD.
This page was last edited on 14 October 2024, at 15:23 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The Treatment and Research Advancements National Association for Personality Disorders (TARA-APD) campaigned unsuccessfully to change the name and designation of BPD in DSM-5, published in May 2013, in which the name "borderline personality disorder" remains unchanged and it is not considered a trauma- and stressor-related disorder.
The term 'borderline' stems from a belief some individuals were functioning on the edge of those two categories, and a number of the other personality disorder categories were also heavily influenced by this approach, including dependent, obsessive–compulsive and histrionic, [116] the latter starting off as a conversion symptom of hysteria ...
According to the DSM-5, differentiating borderline intellectual functioning and mild intellectual disability requires careful assessment of adaptive and intellectual functions and their variations, especially in the presence of co-morbid psychiatric disorders that may affect patient compliance with standardized test (for example, attention deficit hyperactivity disorder (ADHD) with severe ...
The Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) is a standardized, diagnostic rating scale designed to measure the severity and changes in the symptoms of borderline personality disorder (BPD) over time. [1] [2] The assessment was developed by Mary Zanarini and her colleagues at McLean Hospital and released in 2003. [3]
Several random controlled trials comparing DBT to other forms of cognitive-behavioral treatments have favored the use of DBT to treat borderline patients. Specifically, DBT has been found to significantly reduce self-injury, suicidal behavior, impulsivity, self-rated anger and the use of crisis services among borderline patients.
James F. Masterson (March 25, 1926—April 12, 2010) was a prominent American psychiatrist.. He was an internationally recognized psychiatrist who helped inaugurate the study and treatment of personality disorder including borderline personality disorder and narcissistic personality disorder.